Jiehua Xu Selected Research

Jiehua Xu Research Topics

3	Neoplasms (Cancer) 02/2015 - 08/2013
2	Hypoxia (Hypoxemia) 05/2018 - 01/2017
2	Mitochondrial Diseases (Mitochondrial Disease) 05/2014 - 01/2014
2	Alzheimer Disease (Alzheimer's Disease) 05/2014 - 01/2014
1	Infections 01/2022
1	Ischemic Stroke 01/2020
1	Brain Injuries (Brain Injury) 01/2020
1	Brain Ischemia (Cerebral Ischemia) 01/2020
1	Atrophy 01/2017
1	Liver Neoplasms (Liver Cancer) 01/2015
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2014
1	Prostatic Neoplasms (Prostate Cancer) 08/2013

2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2020 - 05/2014
2	cobaltous chloride (cobalt(II)chloride)IBA 05/2018 - 01/2017
2	Amyloid (Amyloid Fibrils)IBA 05/2014 - 01/2014
1	Chlorpromazine (Thorazine)FDA Link 01/2022
1	Antiviral Agents (Antivirals)IBA 01/2022
1	Chloroquine (Aralen)FDA LinkGeneric 01/2022
1	Sucrose (Saccharose)IBA 01/2022
1	N'- (3,4- dihydroxybenzylidene)- 3- hydroxy- 2- naphthahydrazideIBA 01/2022
1	bafilomycin A1IBA 01/2022
1	Ammonium Chloride (Sal Ammoniac)FDA Link 01/2022
1	ClathrinIBA 01/2022
1	ProgranulinsIBA 01/2020
1	Malondialdehyde (Propanedial)IBA 01/2020
1	Superoxide DismutaseIBA 01/2020
1	Indicators and Reagents (Reagents)IBA 05/2018
1	necrostatin-1IBA 05/2018
1	Beclin-1IBA 01/2017
1	Autophagy-Related ProteinsIBA 01/2017
1	APTIBA 02/2015
1	Pharmaceutical PreparationsIBA 02/2015
1	Membrane Proteins (Integral Membrane Proteins)IBA 01/2015
1	Nucleotide AptamersIBA 01/2015
1	Molecular Probes (Molecular Probe)IBA 01/2015
1	AntioxidantsIBA 01/2014
1	astragaloside AIBA 01/2014
1	Peptides (Polypeptides)IBA 01/2014
1	matrigelIBA 08/2013
1	LuciferasesIBA 08/2013
1	Sincalide FDA Link 08/2013

2	Therapeutics 02/2015 - 01/2015
1	Subcutaneous Injections 08/2013